FDA Inspection 1003867 — Central Jersey Blood Center, Inc.
The FDA completed an inspection of Central Jersey Blood Center, Inc. on Feb 27, 2017 in Eatontown, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 27, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Eatontown, NJ (United States)